Literature DB >> 7096854

Clinicopathologic study of progressive subcortical vascular encephalopathy (Binswanger type) in the elderly.

M Tomonaga, H Yamanouchi, H Tohgi, M Kameyama.   

Abstract

A clinicopathologic study was made of 45 elderly persons whose autopsied brains showed the pathologic changes of progressive subcortical vascular encephalopathy (Binswanger type). Progressive subcortical vascular encephalopathy (PSVE) was observed in 3.8 per cent of all autopsied brains of elderly persons and in 6.7 per cent of the brains of those with cerebrovascular diseases. White matter lesions were graded from I to III (slight to severe). Small infarcts in the basal ganglia, thalamus, and pons were common, but the cerebral cortex was usually preserved. Neuropsychiatric symptoms included dementia, urinary incontinence, hemiplegia, pseudobulbar palsy, psychosis, parkinsonism, and mutism. In thge Grade III group there was a high incidence of pseudobulbar palsy, parkinsonism, and mutism. Pathologic study showed marked cerebral arteriosclerosis in almost all cases. Angionecrosis was observed in 60 to 80 per cent. Fibrotic and stenotic changes of the blood vessels in the deep white matter were also noted, particularly in 90 per cent of the Grade III cases. A suggested explanation for the pathogenesis of PSVE is based on the effects of various complications such as hypertension, cardiac disease and malnutrition which may play an important role in PSVE when they occur in elderly persons with a history of long-standing hypertension, marked cerebral arteriosclerosis, and arteriolar changes in the cerebral white matter.

Entities:  

Mesh:

Year:  1982        PMID: 7096854     DOI: 10.1111/j.1532-5415.1982.tb01691.x

Source DB:  PubMed          Journal:  J Am Geriatr Soc        ISSN: 0002-8614            Impact factor:   5.562


  10 in total

Review 1.  The clinical manifestations and pathophysiology of cerebral small vessel disease.

Authors:  Ai-Juan Zhang; Xin-Jun Yu; Mei Wang
Journal:  Neurosci Bull       Date:  2010-06       Impact factor: 5.203

Review 2.  Binswanger's encephalopathy: a review.

Authors:  C M Fisher
Journal:  J Neurol       Date:  1989-02       Impact factor: 4.849

3.  Multifactorial genesis of neuroradiological "leucoencephalopathies.".

Authors:  K Kuchelmeister; G Fahrendorf; F Gullotta; M Tegenthoff
Journal:  Neurosurg Rev       Date:  1991       Impact factor: 3.042

4.  Loss of nerve fibres in the corpus callosum of progressive subcortical vascular encephalopathy.

Authors:  H Yamanouchi; S Sugiura; H Shimada
Journal:  J Neurol       Date:  1990-02       Impact factor: 4.849

5.  Treatment for aging brains.

Authors:  P H Millard
Journal:  Br Med J (Clin Res Ed)       Date:  1984-10-27

6.  Calcium supplementation and risk of dementia in women with cerebrovascular disease.

Authors:  Jürgen Kern; Silke Kern; Kaj Blennow; Henrik Zetterberg; Margda Waern; Xinxin Guo; Anne Börjesson-Hanson; Ingmar Skoog; Svante Östling
Journal:  Neurology       Date:  2016-08-17       Impact factor: 9.910

7.  Decrease in nerve fibres in cerebral white matter in progressive subcortical vascular encephalopathy of Binswanger type. An electron microscopic study.

Authors:  H Yamanouchi; S Sugiura; M Tomonaga
Journal:  J Neurol       Date:  1989-10       Impact factor: 4.849

8.  Primary central white matter degeneration in old dogs.

Authors:  I Ferrer; M Pumarola; R Rivera; M J Zújar; F Cruz-Sánchez; A Vidal
Journal:  Acta Neuropathol       Date:  1993       Impact factor: 17.088

9.  Subtypes and proportions of cerebrovascular disease in an autopsy series in a Japanese geriatric hospital.

Authors:  H Yamanouchi; H Shimada; K Kuramoto
Journal:  Klin Wochenschr       Date:  1990-12-04

10.  MRI features of Binswanger's disease predict prognosis and associated pathology.

Authors:  Ichiro Akiguchi; Herbert Budka; Yoshitomo Shirakashi; Adelheid Woehrer; Toshiyuki Watanabe; Akihiko Shiino; Yasumasa Yamamoto; Yasuhiro Kawamoto; Wolfgang Krampla; Susanne Jungwirth; Peter Fischer
Journal:  Ann Clin Transl Neurol       Date:  2014-10-06       Impact factor: 4.511

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.